comparemela.com

Gilles Favre News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Onxeo Reports Full Year 2022 Financial Results and Provides Clinical Development Updates

Phase 1b/2 trial of AsiDNA™ in combination with olaparib in the United States in recurrent ovarian, breast and metastatic castration-resistant prostate cancer continues to enroll. | April 24, 2023

United statesSan antonioFrance generalShefali agarwalInstitut curieJulien miaraGustave roussyJudith grecietOnxeo sa euronextDanielle guyot caparrosMarie dutreix institut curieDrug administrationGilles favre toulouse cancer research centerCompany groupAnticancer therapies congressEuropean union

Onxeo to Present New Preclinical Data Highlighting AsiDNA s Ability to Fight Tumor Resistance and Protect From Anticancer Treatment Toxicity at AACR Annual Meeting 2022

AsiDNA proven to overcome resistance to tyrosine kinase inhibitors in lung cancer models AsiDNA proven to protect healthy cells when combined with conventional antitumor treatments Regulatory

United statesFrance generalWael jdeyNicolas merigeauOnxeo sa euronextValerie leroyEmmanuel huynhMarie dutreix institut curieAmerican association for cancer research annual meetingGilles favre cancer research centerCompany groupEuronext growth parisFirst north copenhagenAmerican associationCancer research annual meetingGilles favre

Onxeo : to present new preclinical data highlighting AsiDNA™ s ability to fight tumor resistance and protect from anticancer treatment toxicity at AACR Annual Meeting 2022

AsiDNA™ proven to overcome resistance to tyrosine kinase inhibitors in lung cancer models AsiDNA™ proven to protect healthy cells when combined with. | March 31, 2022

United statesFrance generalWael jdeyOnxeo sa euronextMarie dutreix institut curieAmerican association for cancer research annual meetingGilles favre cancer research centerEuronext growth parisFirst north copenhagenAmerican associationCancer research annual meetingGilles favreCancer research centerMarie dutreixInstitut curiePreclinical lead

Onxeo S A : Onxeo Announces Formation of Scientific Advisory Committee of Leading Independent Experts

This newly formed committee of international specialists will advise on the scientific and clinical aspects related to the development of Onxeo's current and future programs Regulatory News: Onxeo

United statesFrance generalUnited kingdomNicolas merigeauGilbert chuRuth plummerJudith grecietEmmanuel huynhLorenzo galluzziGilles favreOnxeo sa euronextValerie leroyGustave roussyCaroline robertInstitut curieNewcastle experimental cancer medicine centre

vimarsana © 2020. All Rights Reserved.